Close
ACHEMA MIDDLE EAST 2026

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare and serious lung disease....

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

The FDA has granted approval to begin clinical trials of the AD-NP1 drug. It is a first-in-class drug for tissue regeneration, which targets cellular...

US FDA Launches Fast-Track Review Scheme for Generic Drugs

The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within the United States, marking...

AbbVie Launches New API Manufacturing Facility in Illinois

AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone in its strategy to...

Amgen to Expand U.S. Manufacturing with $650M Investment

Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

Lilly to Build $6.5B API Manufacturing Facility in Houston

Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

GSK to Invest $30B in Drug Manufacturing and R&D in the US

GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United States. The announcement includes...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...